Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection

Infection and Immunity

Volumn 65, Issue 7, 1997, Pages 2693-2699

  Peterson, Ellena M ^a   Cheng, Xun ^a   Motin, Vladimir L ^a   De la Maza, Luis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; IMMUNE RESPONSE; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VAGINITIS;

EID: 0030915235     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.7.2693-2699.1997     Document Type: Article

References (31)

1. Barclay, A. N., and D. W. Mason. 1982. Induction of Ia antigen in rat epithelial cells and gut epithelium by immunological stimuli. J. Exp. Med. 156:1665-1676.
2. Becherel, P.-A., M. D. Mossalayi, F. Ouaaz, L. Le Goff, B. Dugas, N. Paul-Eugene, C. Frances, O. Chosidow, E. Kilchherr, J.-J. Guillosson, P. Debre, and M. Arock. 1994. Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of FcεRII/CD23+ normal human keratinocytcs. J. Clin. Invest. 93:2275-2274.
3. Blumberg, R. S., T. Koss, C. M. Story, D. Barisnni, J. Polischuk, A. Lipin, L. Pablo, R. Green, and N. E. Simisier, 1995. A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J. Clin. Invest. 95:2397-2402.
4. Brandt, W. E., J. M. McCowan, F. H. Top, Jr., W. H. Bancroft, and P. K. Russell, 1979. Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect. Immun. 26:534-541.
5. Byrne, G. I., R. S. Stephens, G. Ada, H. D. Caldwell, H. Su, R. P. Morrison, B. Van der Pol, P. Bavoil, L. Dobo, S. Everson, Y. Ho, R. C. Hsia, K. Kennedy, C.-C. Kuo, P. C. Montgomery, E. Peterson, A. Swanson, C. Whitaker, J. Whittum-Hudson, C. L. Yang, Y.-X. Zhang, and G. M. Zhong. 1993. Workshop on the in vitro neutralization of Chlamydia trachomatis: summary of proceedings. J. Infect. Dis. 168:415-420.
6. Cheng, X., S. Pal, L. M. de la Maza, and E. M. Peterson. 1992. Characterization of the humoral response induced by a poptide corresponding to variable domain IV of the major outer membrane protein of Chlamydia trachomatis serovar E. Infect. Immun. 60:3428-3432.
7. Cotter, T. W., Q. Meng, Z.-L. Shen, Y.-X. Zhang, H. Su, and H. D. Caldwell. 1995. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4704-4714.
8. Denning, G. M. 1996. IL-4 and IFN-γ synergistically increase total polymeric IgA receptor levels in human intestinal epithelial cells. J. Immunol. 156: 4807-4814.
9. Henry-Suchet, J., F. Catalan, V. Loffredo, M. J. Sanson, C. Debache, F. Pigeau, and R. Coppin. 1981. Chlamydia trachomatis associated with chronic inflammation in abdominal specimens from women selected for tuboplasty. Fertil. Steril. 36:599-605.
10. Homsy, J., M. Meyer, M. Tatano, S. Clarkson, and J. A. Levy. 1989. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cell lines. Science 244:1357-1360.
11. Knight, S. C., S. Iqball, C. Woods, A. Stagg, M. E. Ward, and M. Tuffrey. 1995. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo. Immunology 85:8-15.
12. Mady, B. J., D. V. Erbe, I. Kurane, M. W. Fanger, and F. A. Ennis. 1991. Antibody-dependent enhancement of dengue virus infection mediated by hispccific antibodies against cell surface molecules other than Fcγ receptors, J. Immunol. 147:3139-3144.
13. Morrison, R. P., D. S. Manning, and H. D. Caldwell. 1992. Immunology of Chlamydia trachomatis infections, p. 57-84. In T. C. Quinn (ed.), Sexually transmitted diseases. Raven Press, New York, N.Y.
14. Peterson, E. M., R. Oda, P. Tse, C. Gastaldi, S. C. Stone, and L. M. de la Maza. 1989. Comparison of a single-antigen microimmunofluorescence assay and inclusion fluorescent-antibody assay for detecting chlamydial antibodies and correlation of the results with neutralizing ability. J. Clin. Microbiol. 27:350-352.
15. Peterson, E. M., B. A. Markoff, J. Schachter, and L. M. de la Maza. 1990. The 7.5 kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Plasmid 23:144-148.
16. Peterson, E. M., X. Cheng, B. A. Markoff, T. J. Fielder, and L. M. de la Maza. 1991. Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies. Infect. Immun. 59:4147-4153.
17. Peterson, E. M., X. Cheng, S. Pal, and L. M. de la Maza. 1993. The effect of antibody isotype and host cell on in vitro neutralisation of Chlamydia trachomatis. Infect. Immun. 61:498-503.
18. Qu, Z., X. Cheng, L. M. de lu Maza, and E. M. Peterson. 1993. Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars. Infect. Immun. 61:1305-1370.
19. Robinson, W. E., D. C. Montefiori, and W. M. Mitchell. 1988. Antibodydependent enhancement of human immunodeficiency virus type I infection. Lancet 1:790-794.
20. Schachter, J. 1985. Overview of Chlamydia trachomatis infection and the requirements for a vaccine. Rev. Infect. Dis. 7:713-716.
21. Su, H., and H. D. Caldwell. 1992. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein. J. Exp. Med. 175:227-235.
22. Su, H., G. J. Spangrude, and H. D. Caldwell. 1991. Expression of FcγRIII on HeLa 229 cells: possible effect on in vitro neutralization of Chlamydia trachomatis. Infect. Immun. 59:3811-3814.
23. Su, H., M. Parnell, and H. D. Caldwell. 1995. Protective efficacy of a parcnterally administered MOMP-dcrivcd synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against genital tract infection. Vaccine 13:1023-1032.
24. Su, H., L. Raymond, D. D. Rockey, E. Fischer, T. Hackstadt, and H. D. Caldwell. 1990. A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc. Natl. Acad. Sci. USA 93:1143-11148.
25. Takeda, A., and F. A. Ennis. 1990. FcR-mediated enhancement of HIV-1 infection by antibody. AIDS Res. Hum. Retroviruses 6:999-1004.
26. Takeda, A., C. U. Tuazon, and F. A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242:580-583.
27. Taylor-Rohinson, D., and M. E. Ward. 1989, Immunity to chlamydial infections and the outlook for vaccination, p. 67-85. In A. Meheus and R. E. Spier (ed.), Vaccines for sexually transmitted diseases. Butterworths. London, United Kingdom.
28. Tuffrey, M., P. Falder, and D. Taylor-Robinson. 1982. Genital tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br. J. Exp. Pathol. 63:539-546.
29. Tuffrey, M., F. Alexander, W. Conlan, C. Woods, and D. Taylor-Robinson. 1992. Hetcrotypic protection of mice against chlumydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein, J. Gen. Microbiol. 138:1707-1715.
30. Ulstein, M., T. S. Jensen, and R. Matre. 1993. Demonstration of Fc-y receptors in human endometrium. Acta Obstet. Gynecol. Scand. 72:4-9.
31. Zhang, Y.-X., S. Stewart, T. Joseph, H. R. Taylor, and H. D. Caldwell. 1987. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J. Immunol. 138:575-581.